🔗 Permalink

Inventor profile of:

Cecile BAUCHE

City:

Paris

Country:

France

Published Applications:

Last publication date:

2025-11-13

Top Assignees for applications by Cecile BAUCHE

The entities that hold a legal rights for patent applications filed by inventor BAUCHE Cecile:

Institut Pasteur 6 Paris, France
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE 5 PARIS, France
THERAVECTYS 4 VILLEJUIF, France
Institut National De La Sante Et De La Recherche Medicale (INSERM) 2 Paris, France
Theravectys 2 Paris, France
Cécile Bauche 1 Paris, France
LUDWIG INSTITUT FOR CANCER RESEARCH 1 New York, NY United States
Centre National de la Recherche Scientique 1 Paris, France
Renaud Vaillant 1 Gentilly, France
Institut Pasteur, a corporation of France 1 Paris, France
Ludwig Institute for Cancer, a corporation of New York 1 New York, NY United States
Alaya.bio Inc. 1 Cambridge, MA United States
SORBONNE UNIVERSITE 1 Paris, France
Institut Curie 1 Paris, France

Recent patent applications by BAUCHE Cecile

Cecile BAUCHE from Paris, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-11-13

US20250345456A1

Human necessities

Targeted Poly(beta-amino ester)s

#2 | 2023-05-04

US20230140346A1

Chemistry; metallurgy

Promoter Sequences for In Vitro and In Vivo Expression of Gene Therapy Products in CD3+ Cells

#3 | 2022-12-22

US20220403416A1

Chemistry; metallurgy

Polymer-Encapsulated Viral Vectors for In Vivo Genetic Therapy

#4 | 2022-12-22

US20220403391A1

Chemistry; metallurgy

Aptamer-Based Multispecific Therapeutic Agents

#5 | 2022-12-08

US20220389158A1

Chemistry; metallurgy

DMSO-Free Synthesis of Oligopeptide-Modified Poly(Beta-Amino Ester)s and Their Use in Nanoparticle Delivery Systems

#6 | 2022-08-11

US20220251562A1

Chemistry; metallurgy

Anti-CD3 Aptamers for Use in Cell Targeting and Labeling

#7 | 2021-09-23

US20210292760A1

Chemistry; metallurgy

Aptamer-based CAR T-cell switch

#8 | 2021-01-14

US20210009653A1

Chemistry; metallurgy

LENTIVIRAL VECTORS FOR REGULATED EXPRESSION OF A CHIMERIC ANTIGEN RECEPTOR MOLECULE

#9 | 2020-11-19

US20200360297A1

Human necessities

Polymer-Encapsulated Viral Vectors for Genetic Therapy

#10 | 2020-06-25

US20200199620A1

Chemistry; metallurgy

Viral vector constructs for expression of genetic adjuvants activating the CD40 and STING pathways

#11 | 2019-10-31

US20190328872A1

Human necessities

Viral vector constructs for expression of genetic adjuvants activating the STING pathway

#12 | 2017-12-21

US20170362607A1

Chemistry; metallurgy

USE OF NON-SUBTYPE B GAG PROTEINS FOR LENTIVIRAL PACKAGING

#13 | 2017-06-15

US20170166623A1

Chemistry; metallurgy

Lentiviral vectors for regulated expression of a chimeric antigen receptor molecule

#14 | 2017-02-09

US20170037430A1

Chemistry; metallurgy

Lyophilized lentiviral vector particles, compositions and methods

#15 | 2016-12-29

US20160375119A1

Human necessities

Vectors for molecule delivery to CD11b expressing cells

#16 | 2016-11-17

US20160331831A1

Human necessities

Lentiviral vectors for generating immune responses against human T Lymphotrophic Virus Type 1

#17 | 2015-07-02

US20150182617A1

Human necessities

GLYCOPROTEINS FOR PSEUDOTYPING LENTIVECTORS

#18 | 2014-12-04

US20140356946A1

Chemistry; metallurgy

Lentiviral vectors containing an MHC class I, MHC class II, or B2 microglobulin upstream promoter sequence

#19 | 2014-08-21

US20140234908A1

Chemistry; metallurgy

Use of non-subtype B gag proteins for lentiviral packaging

#20 | 2014-05-01

US20140120132A1

Chemistry; metallurgy

Lentiviral vectors containing an MHC class I promoter

#21 | 2012-08-23

US20120214206A1

Human necessities

Vectors for molecule delivery to CD11b expressing cells

#22 | 2011-03-15

US11713708

Modified adenylate cyclase comprising or lacking CD11b/CD18 interaction domain and uses thereof

#23 | 2010-12-09

US20100310594A1

Chemistry; metallurgy

RECOMBINANT ADENYLATE CYCLASE TOXIN OF BORDETELLA INDUCES T CELL RESPONSES AGAINST TUMORAL ANTIGENS

#24 | 2009-05-07

US20090117143A1

Chemistry; metallurgy

Recombinant adenylate cyclase toxin of induces T cell responses against tumoral antigens

#25 | 2007-02-01

US20070026022A1

Human necessities

Recombinant adenylate cyclase toxin of Bordetella induces T cell responses against tumoral antigens

#26 | 2006-07-20

US20060159697A1

Chemistry; metallurgy

Modified bordetella adenylate cyclase comprising or lacking CD11b/CD18 interaction domain and uses thereof

#27 | 2005-12-08

US20050271679A1

Chemistry; metallurgy

Recombinant adenylate cyclase toxin of Bordetella induces T cell responses against tumoral antigens

#28 | 2005-10-27

US20050238637A1

Human necessities

Vectors for molecule delivery to CD11b expressing cells

InventorID:

744984 ⎘